CPC C07K 14/212 (2013.01) [A61K 39/1045 (2013.01); A61K 39/39 (2013.01); A61P 31/04 (2018.01); C07K 16/1218 (2023.08); A61K 2039/55544 (2013.01); C07K 2319/55 (2013.01)] | 3 Claims |
1. A method for protecting animals or humans from infection of Acinetobacter baumannii or a method for preventing and/or treating with diseases caused by Acinetobacter baumannii, which comprises the following steps:
immunizing a non-human animal or a human with a biomaterial to achieve resistance to Acinetobacter baumannii infection, wherein the biomaterial is one of the following:
1) a protein consisting of 39 amino acids in the N-terminal α-helix part of the Ata protein transport functional domain of Acinetobacter baumannii;
2) a protein composition consisting of 39 amino acids in the N-terminal α-helix part of the Ata protein transport functional domain of Acinetobacter baumannii and an adjuvant protein or a protein fragment with adjuvant function;
3) a fusion protein consisting of 39 amino acids in the N-terminal α-helix part of the Ata protein transport functional domain of Acinetobacter baumannii and an adjuvant protein or a protein fragment with adjuvant function;
wherein the amino acid sequence of said 39 amino acids in the N-terminal α-helix part of the Ata protein transport functional domain of Acinetobacter baumannii is shown as the amino acid residues 127-165 of SEQ ID NO: 2,
wherein the fusion protein is any one of the following a)-c):
a) the amino acid sequence consisting of the amino acid residues shown as SEQ ID NO: 2 in the sequence listing;
b) a fusion protein obtained by attaching a tag to the N-terminal and/or C-terminal of the protein defined in a); and
c) a protein whose amino acid sequence consists of the amino acid residues 20-165 of SEQ ID NO: 2 in the sequence listing.
|